EcadotrilAlternative Names: (S)-acetorphan; Bay-y-7432; BP-1.02; S-049; Sinorphan
Latest Information Update: 03 Dec 2009
At a glance
- Originator Bioprojet
- Developer Bayer; Bioprojet; Shionogi
- Class Antihypertensives; Heart failure therapies; Small molecules; Sulfur amino acids
- Mechanism of Action Endopeptidase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Heart failure; Hypertension